MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202637036817 A) filed by Dong Wha Pharm. Co. , Ltd.; and Pblbiolab Co. , Ltd. on March 26, 2026, for Novel Lactic Acid Bacteria And Use Thereof.
Inventors include Hwang, Yun Ha; Oh, Seong Jun; Won, Dae Yeon; Kim, Su Bin; and Kim, Dong-Hyun.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present invention relates to novel lactic acid bacteria, Bifidobacterium bifidum P61 KCCM13367P, Lactobacillus paracasei P62 KCCM13368P, or a mixture thereof. The novel lactic acid bacteria and the mixture thereof of the present invention change the composition of intestinal microorganisms to inhibit the expression of sarcopenia markers (MuRF-1, MAFbx/Atrogin-1, etc.), increase muscle strength and muscle mass, and promote muscle formation, thereby alleviating sarcopenia. In addition, the present invention improves cognitive dysfunction by inhibiting behavior similar to cognitive dysfunction and regulating the expression of factors (BDNF, IL-10, etc.) associated with said dysfunction. In addition, the present invention has the effect of treating inflammation by reducing the expression of inflammatory markers (TNF-a, IL-6, IL-1ß, and MPO) and increasing the expression of an anti-inflammatory marker (IL-10).
Disclaimer: Curated by HT Syndication.
